Drug: Bevacizumab Injury: Hypertension Quarter: 2016Q3
Total Records: 97 Number of Pages: 5
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 127555931 | Bevacizumab | Hypertension | ROCHE | 61.00 YR | F | 61 KG | 20160916 | US |
| 127576561 | Bevacizumab | Hypertension | ROCHE | 42.00 YR | F | 106 KG | 20160919 | US |
| 127578011 | Bevacizumab | Hypertension | ROCHE | 58.00 YR | F | 62 KG | 20160919 | US |
| 127578121 | Bevacizumab | Hypertension | ROCHE | 74.00 YR | F | 103 KG | 20160919 | US |
| 127615041 | Bevacizumab | Hypertension | ROCHE | 74.80 YR | F | 56 KG | 20160920 | MX |
| 127800251 | Bevacizumab | Hypertension | ROCHE | 66.00 YR | F | 97 KG | 20160926 | US |
| 127825681 | Bevacizumab | Hypertension | ROCHE | 76.00 YR | F | 58 KG | 20160927 | US |
| 127833001 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160927 | JP | |
| 127835681 | Bevacizumab | Hypertension | ROCHE | 69.00 YR | F | 86 KG | 20160927 | US |
| 127850421 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160927 | DE | |
| 127880541 | Bevacizumab | Hypertension | ROCHE | 68.00 YR | F | 60 KG | 20160928 | US |
| 127912991 | BEVACIZUMAB | Hypertension | ROCHE | 61.00 YR | F | 42 KG | 20160929 | US |
| 127973831 | Bevacizumab | Hypertension | ROCHE | 61.00 YR | F | 77 KG | 20160929 | US |
| 127975001 | Bevacizumab | Hypertension | ROCHE | 68.70 YR | F | 0 | 20160930 | US |
| 127977621 | Bevacizumab | Hypertension | ROCHE | 59.00 YR | F | 118 KG | 20160930 | US |
| 877635412 | Bevacizumab | Hypertension | ROCHE | 0.00 | 0 | 20160916 | DE | |
| 1034126913 | Bevacizumab | Hypertension | ROCHE | 73.97 YR | F | 77 KG | 20160829 | US |
Total Records: 97 Number of Pages: 5